[1] Coster DJ. Mechamisms of corneal graft failure; the erosion of corneal privilege[J]. Eye, 1989, 3(2): 151-3. [2] Apel A, Oh C, Chiu R, et al. A subconjunctival degradable implant for cyclosporine delivery in corneal transplant therapy[J]. Curr Eye Res, 1995, 14(8): 659-67. [3] Larkin DFP, Calder VL, Lightman SL. Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection[J]. Clin Exp Immunol, 1997, 107(2): 381-91. [4] 吕岚,张文华,孙旭光.FK-506抑制大鼠角膜移植排斥反应的研究[J].中华眼科杂志,1999,35(1):25-8.LüL, Zhang WH, Sun XG. Experimental studies on the effect of the immunosuppressant FK 506 on penetrating keratoplasty rejection model in rats[J]. Chin J Ophthalmol, 1999, 35(1): 25-8. [5] Dana MR, Zhu SN, Yamada J. Topical modulation ofinterleukin-1 activity in corneal neovascularization [J]. Cornea, 1998, 17(4): 403-9. [6] BenEzra D, Hemo I, Mafizir G. In vivo antigenic activity of interleukins[J]. Arch Ophthalmol, 1994, 108(5): 573-6. [7] Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin- 1 inhibitor [J]. Nature, 1990,343(6256): 336-40. [8] 翟长斌,张文华,邹留河,等.白细胞介素-l受体拮抗剂防治角膜移植免疫排斥反应的实验研究[J].中华眼科杂志,2001,37(4):270-2.Zhai CB, Zhang WH, Zou LH, et al. An experimental study on subconjunctival interleukin-1 receptor antagonist for promotion of corneal transplant survival [J]. Chin J Ophthalmol, 2001, 37(4):270-2. [9] 郭金华,查家华,陈国苍.IL-1ra对大鼠角膜移植免疫排斥反应的抑制作用[J].眼科研究,2001,19(3):195-7.Guo JH, Zha JH, Chen GC. The effects of IL-lra on penetrating keratoplasty rejection in rat[J]. Chin Oph Res, 2001, 19(3): 195-7. |